Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer-Reference-Cited by-同舟云学术

Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer

Published:2019-07-26 Issue:1 Volume:4 Page:
ISSN:2059-3635
Container-title:Signal Transduction and Targeted Therapy
language:en
Short-container-title:Sig Transduct Target Ther

Author:

Zheng Heng,Tie Yan,Fang Zhen^ORCID,Wu Xiaoai,Yi Tao,Huang Shuang,Liang Xiao,Qian Yanping,Wang Xi,Pi Ruyu,Chen Siyuan,Peng Yong^ORCID,Yang Shengyong,Zhao Xia,Wei Xiawei

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics

Link

http://www.nature.com/articles/s41392-019-0055-8.pdf

Reference58 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).

2. Prat, J. FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J. Gynecol. Oncol. 26, 87–89 (2015).

3. Jayson, G. C., Kohn, E. C., Kitchener, H. C. & Ledermann, J. A. Ovarian cancer. Lancet (London, England) 384, 1376–1388 (2014).

4. Lin, X. et al. RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells. Signal Trans. Targeted Ther. 3, 23 (2018).

5. Liu, J. & Matulonis, U. A. New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 20, 5150–5156 (2014).

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances;MedComm – Oncology;2024-01-04

2. Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma;BMC Cancer;2024-01-02

3. A Precise and Intelligent Nanomedicine for Salivary Adenoid Cystic Carcinoma Treatment by Combining Antivascular Photodynamic Therapy and Neuroinhibitory Chemotherapy;Advanced Functional Materials;2023-12-15

4. JMJD6–BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells;Journal of Translational Medicine;2023-10-25

5. JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma;BMC Cancer;2023-07-24